HMGB1 Attenuates Cardiac Remodelling in the Failing Heart via Enhanced Cardiac Regeneration and miR-206-Mediated Inhibition of TIMP-3
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HMGB1 Attenuates Cardiac Remodelling in the Failing Heart via Enhanced Cardiac Regeneration and miR-206-Mediated Inhibition of TIMP-3
Authors
Keywords
-
Journal
PLoS One
Volume 6, Issue 6, Pages e19845
Publisher
Public Library of Science (PLoS)
Online
2011-06-23
DOI
10.1371/journal.pone.0019845
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HMGB1: the missing link between diabetes mellitus and heart failure
- (2010) H. Christian Volz et al. BASIC RESEARCH IN CARDIOLOGY
- MicroRNAs Add a New Dimension to Cardiovascular Disease
- (2010) Eric M. Small et al. CIRCULATION
- Expression of microRNA-208 is Associated With Adverse Clinical Outcomes in Human Dilated Cardiomyopathy
- (2010) Mamoru Satoh et al. JOURNAL OF CARDIAC FAILURE
- TIMP3: a physiological regulator of adult myogenesis
- (2010) H. Liu et al. JOURNAL OF CELL SCIENCE
- High-Mobility Group Box 1 Promotes Metalloproteinase-9 Upregulation Through Toll-Like Receptor 4 After Cerebral Ischemia
- (2010) Jianhua Qiu et al. STROKE
- Exogenous high-mobility group box 1 improves myocardial recovery after acute global ischemia/reperfusion injury
- (2010) Aaron M. Abarbanell et al. SURGERY
- Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction
- (2009) Zhi-Xin Shan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNAs
- (2009) Kurt G. Barringhaus et al. CIRCULATION
- Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia
- (2009) Simona Greco et al. FASEB JOURNAL
- TIMPs and cardiac remodeling: ‘Embracing the MMP-independent-side of the family’
- (2009) Davy Vanhoutte et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Optimising management of chronic heart failure
- (2009) Henry Krum LANCET
- MicroRNA-1 Negatively Regulates Expression of the Hypertrophy-Associated Calmodulin and Mef2a Genes
- (2009) S. Ikeda et al. MOLECULAR AND CELLULAR BIOLOGY
- Tissue inhibitor of metalloproteinases-3 interacts with angiotensin II type 2 receptor and additively inhibits angiogenesis
- (2008) Kyo-Hwa Kang et al. CARDIOVASCULAR RESEARCH
- High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice
- (2008) T. Kitahara et al. CARDIOVASCULAR RESEARCH
- Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling
- (2008) T. Kohno et al. CARDIOVASCULAR RESEARCH
- High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart
- (2008) Martin Andrassy et al. CIRCULATION
- Modulated Inflammation by Injection of High-Mobility Group Box 1 Recovers Post-Infarction Chronically Failing Heart
- (2008) K. Takahashi et al. CIRCULATION
- Effects of HMGB1 on Ischemia-Reperfusion Injury in the Rat Heart
- (2008) Susumu Oozawa et al. CIRCULATION JOURNAL
- Local Activation or Implantation of Cardiac Progenitor Cells Rescues Scarred Infarcted Myocardium Improving Cardiac Function
- (2008) Marcello Rota et al. CIRCULATION RESEARCH
- HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells
- (2008) Alessandra Rossini et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
- (2008) Thomas Thum et al. NATURE
- Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
- (2008) E. van Rooij et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started